Soliris
Payments companies reported to CMS as associated with Soliris. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Soliris, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Soliris
These are the largest totals companies reported as associated with Soliris. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anuja Java | Saint Louis, MO | Nephrology (Internal Medicine) | $74,729.21 |
| Benjamin Osborne | Washington, DC | Neurology (Psychiatry & Neurology) | $63,285.35 |
| Aram Zabeti | Cincinnati, OH | Neurology (Psychiatry & Neurology) | $52,926.30 |
| Rosemarie Walch | Owosso, MI | Neurology (Psychiatry & Neurology) | $48,631.73 |
| Ann Bass | San Antonio, TX | Neurology (Psychiatry & Neurology) | $43,850.43 |
| Derrick Robertson | Tampa, FL | Neurology (Psychiatry & Neurology) | $31,875.28 |
| Michael Levy | Boston, MA | Neurology (Psychiatry & Neurology) | $31,406.16 |
| Ahmed Obeidat | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $30,968.22 |
| Jeffrey Bennett | Aurora, CO | Neurology (Psychiatry & Neurology) | $29,174.40 |
| Richard Burwick | West Covina, CA | Maternal & Fetal Medicine | $28,913.28 |
Prescribed Soliris?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.